Skip to main content
Top
Published in: Journal of Neuro-Oncology 2/2012

01-01-2012 | Letter to the Editor

Eltrombopag for radiation-induced thrombocytopenia in a glioblastoma patient

Authors: J. Paul Duic, Jai Grewal, Kerry McConie, Harry Staszewski, Jonathan Haas, Santosh Kesari

Published in: Journal of Neuro-Oncology | Issue 2/2012

Login to get access

Excerpt

To the Editor, …
Literature
1.
go back to reference Corman SL, Mohammad RA (2010) Eltrombopag: a novel oral thrombopoietin receptor agonist. Ann Pharmacother 44(6):1072–1079PubMedCrossRef Corman SL, Mohammad RA (2010) Eltrombopag: a novel oral thrombopoietin receptor agonist. Ann Pharmacother 44(6):1072–1079PubMedCrossRef
2.
go back to reference Kellum A et al (2010) A randomized, double-blind, placebo-controlled, dose ranging study to assess the efficacy and safety of eltrombopag in patients receiving carboplatin/paclitaxel for advanced solid tumors. Curr Med Res Opin 26(10):2339–2346PubMedCrossRef Kellum A et al (2010) A randomized, double-blind, placebo-controlled, dose ranging study to assess the efficacy and safety of eltrombopag in patients receiving carboplatin/paclitaxel for advanced solid tumors. Curr Med Res Opin 26(10):2339–2346PubMedCrossRef
3.
go back to reference Jenkins JM et al (2007) Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist. Blood 109(11):4739–4741PubMedCrossRef Jenkins JM et al (2007) Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist. Blood 109(11):4739–4741PubMedCrossRef
Metadata
Title
Eltrombopag for radiation-induced thrombocytopenia in a glioblastoma patient
Authors
J. Paul Duic
Jai Grewal
Kerry McConie
Harry Staszewski
Jonathan Haas
Santosh Kesari
Publication date
01-01-2012
Publisher
Springer US
Published in
Journal of Neuro-Oncology / Issue 2/2012
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-011-0675-5

Other articles of this Issue 2/2012

Journal of Neuro-Oncology 2/2012 Go to the issue